Acurx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Adaptive Biotechnologies Corporation
|
170.27 Million USD
|
98.02%
|
IO Biotech, Inc.
|
- USD
|
-Infinity%
|
VYNE Therapeutics Inc.
|
424 Thousand USD
|
-695.047%
|
Organovo Holdings, Inc.
|
109 Thousand USD
|
-2992.661%
|
TNF Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Lexaria Bioscience Corp.
|
226.2 Thousand USD
|
-1390.221%
|
Tonix Pharmaceuticals Holding Corp.
|
7.76 Million USD
|
56.604%
|
Aadi Bioscience, Inc.
|
24.35 Million USD
|
86.158%
|
Savara Inc.
|
- USD
|
-Infinity%
|
Aerovate Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Rocket Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Corbus Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
ZyVersa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Soligenix, Inc.
|
839.35 Thousand USD
|
-301.616%
|
Aptose Biosciences Inc.
|
- USD
|
-Infinity%
|
NKGen Biotech, Inc. Common Stock
|
- USD
|
-Infinity%
|
Century Therapeutics, Inc.
|
2.23 Million USD
|
-50.828%
|
Eterna Therapeutics Inc.
|
68 Thousand USD
|
-4857.353%
|
Precision BioSciences, Inc.
|
48.72 Million USD
|
93.082%
|
Axsome Therapeutics, Inc.
|
270.6 Million USD
|
98.754%
|
Kura Oncology, Inc.
|
- USD
|
-Infinity%
|
Xenetic Biosciences, Inc.
|
2.53 Million USD
|
-32.717%
|
Dyadic International, Inc.
|
2.89 Million USD
|
-16.289%
|
TScan Therapeutics, Inc.
|
21.04 Million USD
|
83.985%
|
IDEAYA Biosciences, Inc.
|
23.38 Million USD
|
85.585%
|
CytomX Therapeutics, Inc.
|
101.21 Million USD
|
96.669%
|
Autolus Therapeutics plc
|
1.69 Million USD
|
-98.528%
|
Eton Pharmaceuticals, Inc.
|
31.64 Million USD
|
89.346%
|
EyePoint Pharmaceuticals, Inc.
|
46.01 Million USD
|
92.675%
|
GRI Bio, Inc.
|
21.76 Million USD
|
84.513%
|
Tenaya Therapeutics, Inc.
|
- USD
|
-Infinity%
|
IGM Biosciences, Inc.
|
2.13 Million USD
|
-58.263%
|
Heron Therapeutics, Inc.
|
127.04 Million USD
|
97.347%
|
SAB Biotherapeutics, Inc.
|
2.23 Million USD
|
-50.559%
|
Entero Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Opthea Limited
|
261.85 Thousand USD
|
-1187.334%
|
X4 Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Atara Biotherapeutics, Inc.
|
8.57 Million USD
|
60.679%
|
Pliant Therapeutics, Inc.
|
1.58 Million USD
|
-113.354%
|
Ligand Pharmaceuticals Incorporated
|
131.31 Million USD
|
97.433%
|
Surrozen, Inc.
|
- USD
|
-Infinity%
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
Cingulate Inc.
|
- USD
|
-Infinity%
|
Ovid Therapeutics Inc.
|
391.69 Thousand USD
|
-760.619%
|
Sorrento Therapeutics, Inc.
|
62.83 Million USD
|
94.635%
|
Acelyrin, Inc.
|
- USD
|
-Infinity%
|
Centessa Pharmaceuticals plc
|
6.85 Million USD
|
50.81%
|
Hepion Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Arcturus Therapeutics Holdings Inc.
|
157.74 Million USD
|
97.863%
|
Syros Pharmaceuticals, Inc.
|
9.93 Million USD
|
66.073%
|
ADMA Biologics, Inc.
|
258.21 Million USD
|
98.694%
|
PureTech Health plc
|
3.33 Million USD
|
-1.231%
|
Oncternal Therapeutics, Inc.
|
785 Thousand USD
|
-329.427%
|
FibroBiologics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Barinthus Biotherapeutics plc
|
802 Thousand USD
|
-320.324%
|
Kymera Therapeutics, Inc.
|
78.59 Million USD
|
95.711%
|
Synaptogenix, Inc.
|
- USD
|
-Infinity%
|
Tiziana Life Sciences Ltd
|
- USD
|
-Infinity%
|
ChromaDex Corporation
|
83.57 Million USD
|
95.966%
|
Inhibikase Therapeutics, Inc.
|
260.5 Thousand USD
|
-1194.05%
|
Monopar Therapeutics Inc.
|
- USD
|
-Infinity%
|
Exelixis, Inc.
|
1.83 Billion USD
|
99.816%
|
Akebia Therapeutics, Inc.
|
194.62 Million USD
|
98.268%
|
Better Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Nurix Therapeutics, Inc.
|
76.98 Million USD
|
95.621%
|
Apellis Pharmaceuticals, Inc.
|
396.59 Million USD
|
99.15%
|
Sangamo Therapeutics, Inc.
|
176.23 Million USD
|
98.087%
|
Seer, Inc.
|
15.18 Million USD
|
77.796%
|
Aridis Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
LAVA Therapeutics N.V.
|
6.76 Million USD
|
50.199%
|
Gritstone bio, Inc.
|
1.33 Million USD
|
-153.268%
|
Jasper Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Avid Bioservices, Inc.
|
139.91 Million USD
|
97.591%
|
Insmed Incorporated
|
305.2 Million USD
|
98.896%
|
Panbela Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Avalo Therapeutics, Inc.
|
1.92 Million USD
|
-75.208%
|
Fate Therapeutics, Inc.
|
63.53 Million USD
|
94.694%
|
MediWound Ltd.
|
18.68 Million USD
|
81.96%
|
BioXcel Therapeutics, Inc.
|
1.38 Million USD
|
-144.275%
|
Fortress Biotech, Inc.
|
84.51 Million USD
|
96.011%
|
OmniAb, Inc.
|
34.16 Million USD
|
90.133%
|
Seres Therapeutics, Inc.
|
126.32 Million USD
|
97.331%
|
Zai Lab Limited
|
266.71 Million USD
|
98.736%
|
Revance Therapeutics, Inc.
|
234.04 Million USD
|
98.56%
|
Tarsus Pharmaceuticals, Inc.
|
17.44 Million USD
|
80.679%
|
Veracyte, Inc.
|
361.05 Million USD
|
99.066%
|
Abeona Therapeutics Inc.
|
3.5 Million USD
|
3.686%
|
FibroGen, Inc.
|
147.75 Million USD
|
97.718%
|
Apogee Therapeutics, Inc.
|
- USD
|
-Infinity%
|
ContextLogic Inc.
|
287 Million USD
|
98.825%
|
Intensity Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Adial Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
HOOKIPA Pharma Inc.
|
20.12 Million USD
|
83.253%
|
Jazz Pharmaceuticals plc
|
3.83 Billion USD
|
99.912%
|
Entrada Therapeutics, Inc.
|
129.01 Million USD
|
97.387%
|
Cyclacel Pharmaceuticals, Inc.
|
420 Thousand USD
|
-702.619%
|
ImmuCell Corporation
|
17.47 Million USD
|
80.706%
|
Fortrea Holdings Inc.
|
3.1 Billion USD
|
99.892%
|
KalVista Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Jasper Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Foghorn Therapeutics Inc.
|
34.15 Million USD
|
90.13%
|
Ultragenyx Pharmaceutical Inc.
|
434.24 Million USD
|
99.224%
|
Theravance Biopharma, Inc.
|
57.42 Million USD
|
94.13%
|
Metagenomi, Inc. Common Stock
|
44.75 Million USD
|
92.468%
|
Vaxxinity, Inc.
|
- USD
|
-Infinity%
|
BioCryst Pharmaceuticals, Inc.
|
331.41 Million USD
|
98.983%
|
Gain Therapeutics, Inc.
|
55.18 Thousand USD
|
-6009.097%
|
Creative Medical Technology Holdings, Inc.
|
9000.00 USD
|
-37355.556%
|
Marker Therapeutics, Inc.
|
3.31 Million USD
|
-1.808%
|
CASI Pharmaceuticals, Inc.
|
33.87 Million USD
|
90.05%
|
Senti Biosciences, Inc.
|
2.56 Million USD
|
-31.628%
|
BioRestorative Therapies, Inc.
|
145.8 Thousand USD
|
-2212.071%
|
Apollomics, Inc.
|
821 Thousand USD
|
-310.597%
|
89bio, Inc.
|
- USD
|
-Infinity%
|
Arrowhead Pharmaceuticals, Inc.
|
240.73 Million USD
|
98.6%
|
TransCode Therapeutics, Inc.
|
- USD
|
-Infinity%
|
RAPT Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Ardelyx, Inc.
|
124.45 Million USD
|
97.291%
|
Pluri Inc.
|
326 Thousand USD
|
-934.049%
|
Prothena Corporation plc
|
91.37 Million USD
|
96.311%
|
Pulmatrix, Inc.
|
7.29 Million USD
|
53.809%
|
Celularity Inc.
|
22.77 Million USD
|
85.196%
|
MeiraGTx Holdings plc
|
14.01 Million USD
|
75.951%
|
Omeros Corporation
|
- USD
|
-Infinity%
|
Ainos, Inc.
|
122.11 Thousand USD
|
-2660.58%
|
Humacyte, Inc.
|
- USD
|
-Infinity%
|
Mesoblast Limited
|
5.9 Million USD
|
42.884%
|
Cocrystal Pharma, Inc.
|
- USD
|
-Infinity%
|
Cidara Therapeutics, Inc.
|
63.9 Million USD
|
94.725%
|
Blueprint Medicines Corporation
|
249.38 Million USD
|
98.648%
|
Cabaletta Bio, Inc.
|
- USD
|
-Infinity%
|
Summit Therapeutics Inc.
|
- USD
|
-Infinity%
|
Alaunos Therapeutics, Inc.
|
5000.00 USD
|
-67320.0%
|
Scholar Rock Holding Corporation
|
- USD
|
-Infinity%
|
Intellia Therapeutics, Inc.
|
36.27 Million USD
|
90.707%
|
Adlai Nortye Ltd. American Depositary Shares
|
4.99 Million USD
|
32.521%
|
Cytokinetics, Incorporated
|
7.53 Million USD
|
55.232%
|
Eloxx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Nutriband Inc.
|
2.08 Million USD
|
-61.654%
|
Protara Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Roivant Sciences Ltd.
|
124.79 Million USD
|
97.299%
|
Evogene Ltd.
|
5.64 Million USD
|
40.23%
|
Applied Therapeutics, Inc.
|
9.99 Million USD
|
66.266%
|
Hoth Therapeutics, Inc.
|
- USD
|
-Infinity%
|
BridgeBio Pharma, Inc.
|
9.3 Million USD
|
63.764%
|
BioLineRx Ltd.
|
4.8 Million USD
|
29.771%
|
Atai Life Sciences N.V.
|
314 Thousand USD
|
-973.567%
|
VistaGen Therapeutics, Inc.
|
1.06 Million USD
|
-216.823%
|
Aurinia Pharmaceuticals Inc.
|
175.51 Million USD
|
98.079%
|
MediciNova, Inc.
|
1 Million USD
|
-237.1%
|
Praxis Precision Medicines, Inc.
|
2.44 Million USD
|
-37.761%
|
MiMedx Group, Inc.
|
321.47 Million USD
|
98.951%
|
PTC Therapeutics, Inc.
|
937.82 Million USD
|
99.641%
|
Cullinan Oncology, Inc.
|
- USD
|
-Infinity%
|
Syndax Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Pasithea Therapeutics Corp.
|
- USD
|
-Infinity%
|
NRx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
4D Molecular Therapeutics, Inc.
|
20.72 Million USD
|
83.733%
|
Dyne Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Kiniksa Pharmaceuticals, Ltd.
|
270.25 Million USD
|
98.753%
|
Ventyx Biosciences, Inc.
|
- USD
|
-Infinity%
|
Allakos Inc.
|
- USD
|
-Infinity%
|
Fulcrum Therapeutics, Inc.
|
2.8 Million USD
|
-20.178%
|
Corcept Therapeutics Incorporated
|
482.37 Million USD
|
99.301%
|
BioAtla, Inc.
|
- USD
|
-Infinity%
|
Allogene Therapeutics, Inc.
|
95 Thousand USD
|
-3448.421%
|
Larimar Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Precigen, Inc.
|
6.22 Million USD
|
45.847%
|
BriaCell Therapeutics Corp.
|
- USD
|
-Infinity%
|
XOMA Corporation
|
4.75 Million USD
|
29.151%
|
Kezar Life Sciences, Inc.
|
7 Million USD
|
51.843%
|
Incyte Corporation
|
3.69 Billion USD
|
99.909%
|
Cara Therapeutics, Inc.
|
20.96 Million USD
|
83.923%
|
Aligos Therapeutics, Inc.
|
15.52 Million USD
|
78.292%
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
CRISPR Therapeutics AG
|
371.2 Million USD
|
99.092%
|
Akero Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Eliem Therapeutics, Inc.
|
- USD
|
-Infinity%
|
EyeGate Pharmaceuticals, Inc.
|
12.05 Thousand USD
|
-27854.225%
|
UroGen Pharma Ltd.
|
82.71 Million USD
|
95.924%
|
Sutro Biopharma, Inc.
|
153.73 Million USD
|
97.807%
|
ZIVO Bioscience, Inc.
|
27.65 Thousand USD
|
-12091.682%
|
Lisata Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Stoke Therapeutics, Inc.
|
8.78 Million USD
|
61.606%
|
Chimerix, Inc.
|
324 Thousand USD
|
-940.432%
|
Outlook Therapeutics, Inc.
|
- USD
|
-Infinity%
|
60 Degrees Pharmaceuticals, Inc.
|
253.57 Thousand USD
|
-1229.4%
|
Enanta Pharmaceuticals, Inc.
|
79.2 Million USD
|
95.744%
|
Aprea Therapeutics, Inc.
|
583.23 Thousand USD
|
-477.987%
|
Portage Biotech Inc.
|
- USD
|
-Infinity%
|
OncoCyte Corporation
|
1.5 Million USD
|
-124.285%
|
Qualigen Therapeutics, Inc.
|
5.2 Million USD
|
35.232%
|
Cadrenal Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Processa Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Purple Biotech Ltd.
|
- USD
|
-Infinity%
|
NextCure, Inc.
|
- USD
|
-Infinity%
|
ProMIS Neurosciences, Inc.
|
- USD
|
-Infinity%
|
Dermata Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Generation Bio Co.
|
5.9 Million USD
|
42.903%
|
Neumora Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Xeris Biopharma Holdings, Inc.
|
163.91 Million USD
|
97.943%
|
TRACON Pharmaceuticals, Inc.
|
12.04 Million USD
|
72.013%
|
NLS Pharmaceutics AG
|
- USD
|
-Infinity%
|
Mineralys Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Novavax, Inc.
|
983.7 Million USD
|
99.657%
|
Virios Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Curis, Inc.
|
10.02 Million USD
|
66.367%
|
Daré Bioscience, Inc.
|
2.8 Million USD
|
-20.055%
|
Titan Pharmaceuticals, Inc.
|
184 Thousand USD
|
-1732.065%
|
Virpax Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Bicycle Therapeutics plc
|
26.97 Million USD
|
87.504%
|
BeiGene, Ltd.
|
2.45 Billion USD
|
99.863%
|
Kiromic BioPharma, Inc.
|
- USD
|
-Infinity%
|
Alector, Inc.
|
97.06 Million USD
|
96.527%
|
Protagonist Therapeutics, Inc.
|
60 Million USD
|
94.382%
|
Erasca, Inc.
|
- USD
|
-Infinity%
|
Checkpoint Therapeutics, Inc.
|
103 Thousand USD
|
-3172.816%
|
Aura Biosciences, Inc.
|
- USD
|
-Infinity%
|
Viracta Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Chemomab Therapeutics Ltd.
|
- USD
|
-Infinity%
|
Protagenic Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Pieris Pharmaceuticals, Inc.
|
42.81 Million USD
|
92.126%
|
BioMarin Pharmaceutical Inc.
|
2.41 Billion USD
|
99.861%
|
Histogen Inc.
|
3.76 Million USD
|
10.56%
|
Fortress Biotech, Inc.
|
84.51 Million USD
|
96.011%
|
Avidity Biosciences, Inc.
|
9.56 Million USD
|
64.738%
|
Lyell Immunopharma, Inc.
|
130 Thousand USD
|
-2493.077%
|
Galecto, Inc.
|
- USD
|
-Infinity%
|
InMed Pharmaceuticals Inc.
|
4.59 Million USD
|
26.681%
|
Phathom Pharmaceuticals, Inc.
|
682 Thousand USD
|
-394.282%
|
Molecular Templates, Inc.
|
57.3 Million USD
|
94.118%
|
PDS Biotechnology Corporation
|
- USD
|
-Infinity%
|
Amylyx Pharmaceuticals, Inc.
|
380.78 Million USD
|
99.115%
|
Amarin Corporation plc
|
306.91 Million USD
|
98.902%
|
TG Therapeutics, Inc.
|
233.66 Million USD
|
98.557%
|
Aptevo Therapeutics Inc.
|
- USD
|
-Infinity%
|
Celldex Therapeutics, Inc.
|
6.88 Million USD
|
51.024%
|
Cogent Biosciences, Inc.
|
- USD
|
-Infinity%
|
Onconetix, Inc.
|
58.46 Thousand USD
|
-5665.843%
|
MacroGenics, Inc.
|
58.74 Million USD
|
94.262%
|
Y-mAbs Therapeutics, Inc.
|
84.81 Million USD
|
96.026%
|
Ocuphire Pharma, Inc.
|
19.04 Million USD
|
82.304%
|
Adagene Inc.
|
18.11 Million USD
|
81.388%
|
Inhibrx Biosciences, Inc.
|
1.8 Million USD
|
-87.278%
|
Cartesian Therapeutics, Inc.
|
26 Million USD
|
87.037%
|
Voyager Therapeutics, Inc.
|
250 Million USD
|
98.652%
|
SciSparc Ltd.
|
2.87 Million USD
|
-17.089%
|
Revelation Biosciences, Inc.
|
- USD
|
-Infinity%
|
Minerva Neurosciences, Inc.
|
- USD
|
-Infinity%
|
Astria Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Black Diamond Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Arcutis Biotherapeutics, Inc.
|
59.6 Million USD
|
94.345%
|
Relay Therapeutics, Inc.
|
25.54 Million USD
|
86.804%
|
Alnylam Pharmaceuticals, Inc.
|
1.82 Billion USD
|
99.816%
|
Psyence Biomedical Ltd.
|
- USD
|
-Infinity%
|
Artelo Biosciences, Inc.
|
- USD
|
-Infinity%
|
2seventy bio, Inc.
|
100.38 Million USD
|
96.642%
|
Clene Inc.
|
654 Thousand USD
|
-415.443%
|
Boundless Bio, Inc. Common Stock
|
- USD
|
-Infinity%
|
GeoVax Labs, Inc.
|
- USD
|
-Infinity%
|
Sonnet BioTherapeutics Holdings, Inc.
|
147.8 Thousand USD
|
-2180.708%
|
Arbutus Biopharma Corporation
|
18.14 Million USD
|
81.418%
|
Scopus BioPharma Inc.
|
- USD
|
-Infinity%
|
Absci Corporation
|
5.71 Million USD
|
41.046%
|
XBiotech Inc.
|
- USD
|
-Infinity%
|
ALX Oncology Holdings Inc.
|
- USD
|
-Infinity%
|
Lyra Therapeutics, Inc.
|
1.55 Million USD
|
-116.367%
|
Entera Bio Ltd.
|
- USD
|
-Infinity%
|
Trevena, Inc.
|
3.12 Million USD
|
-7.872%
|
Adaptimmune Therapeutics plc
|
60.28 Million USD
|
94.408%
|
Caribou Biosciences, Inc.
|
34.47 Million USD
|
90.222%
|
INmune Bio, Inc.
|
155 Thousand USD
|
-2074.839%
|
Citius Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Tyra Biosciences, Inc.
|
- USD
|
-Infinity%
|
Galmed Pharmaceuticals Ltd.
|
- USD
|
-Infinity%
|
Unity Biotechnology, Inc.
|
- USD
|
-Infinity%
|
Tenax Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Jaguar Health, Inc.
|
9.76 Million USD
|
65.465%
|
Clearside Biomedical, Inc.
|
8.22 Million USD
|
59.02%
|
NexImmune, Inc.
|
- USD
|
-Infinity%
|
Connect Biopharma Holdings Limited
|
- USD
|
-Infinity%
|
Clearmind Medicine Inc.
|
- USD
|
-Infinity%
|
Coeptis Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
Kronos Bio, Inc.
|
6.28 Million USD
|
46.39%
|
Innoviva, Inc.
|
310.46 Million USD
|
98.914%
|
Coherus BioSciences, Inc.
|
257.24 Million USD
|
98.69%
|
Regeneron Pharmaceuticals, Inc.
|
13.11 Billion USD
|
99.974%
|
Bolt Biotherapeutics, Inc.
|
7.87 Million USD
|
57.199%
|
Verastem, Inc.
|
- USD
|
-Infinity%
|
ProKidney Corp.
|
- USD
|
-Infinity%
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
Imunon, Inc.
|
- USD
|
-Infinity%
|
Viking Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Statera Biopharma, Inc.
|
- USD
|
-Infinity%
|
ImmunityBio, Inc.
|
622 Thousand USD
|
-441.961%
|
Korro Bio, Inc.
|
- USD
|
-Infinity%
|
Travere Therapeutics, Inc.
|
145.23 Million USD
|
97.679%
|
Kineta, Inc.
|
5.44 Million USD
|
38.056%
|
Catalyst Pharmaceuticals, Inc.
|
398.2 Million USD
|
99.153%
|
Capricor Therapeutics, Inc.
|
25.17 Million USD
|
86.611%
|
GT Biopharma, Inc.
|
- USD
|
-Infinity%
|
Keros Therapeutics, Inc.
|
151 Thousand USD
|
-2132.45%
|
Celularity Inc.
|
22.77 Million USD
|
85.196%
|
Crinetics Pharmaceuticals, Inc.
|
4.01 Million USD
|
15.998%
|
CalciMedica, Inc.
|
- USD
|
-Infinity%
|
Cibus, Inc.
|
1.81 Million USD
|
-85.526%
|
C4 Therapeutics, Inc.
|
20.75 Million USD
|
83.759%
|
Marinus Pharmaceuticals, Inc.
|
30.98 Million USD
|
89.122%
|
Eledon Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Kodiak Sciences Inc.
|
- USD
|
-Infinity%
|
Sana Biotechnology, Inc.
|
- USD
|
-Infinity%
|
Annexon, Inc.
|
- USD
|
-Infinity%
|
Adverum Biotechnologies, Inc.
|
3.6 Million USD
|
6.361%
|
Assembly Biosciences, Inc.
|
7.16 Million USD
|
52.939%
|
Elicio Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Moderna, Inc.
|
6.84 Billion USD
|
99.951%
|
Vigil Neuroscience, Inc.
|
- USD
|
-Infinity%
|
Ionis Pharmaceuticals, Inc.
|
787.64 Million USD
|
99.572%
|
Vor Biopharma Inc.
|
- USD
|
-Infinity%
|
Eyenovia, Inc.
|
3787.00 USD
|
-88915.051%
|
DiaMedica Therapeutics Inc.
|
- USD
|
-Infinity%
|
Puma Biotechnology, Inc.
|
235.63 Million USD
|
98.569%
|
Monte Rosa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Wave Life Sciences Ltd.
|
113.3 Million USD
|
97.025%
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
ACADIA Pharmaceuticals Inc.
|
726.43 Million USD
|
99.536%
|
Immunocore Holdings plc
|
249.42 Million USD
|
98.649%
|
Tango Therapeutics, Inc.
|
36.52 Million USD
|
90.771%
|
Galectin Therapeutics Inc.
|
- USD
|
-Infinity%
|
Alkermes plc
|
1.66 Billion USD
|
99.797%
|
Arcellx, Inc.
|
110.31 Million USD
|
96.944%
|
Renovaro Biosciences Inc.
|
- USD
|
-Infinity%
|
Zentalis Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Sagimet Biosciences Inc.
|
2 Million USD
|
-68.55%
|
Regulus Therapeutics Inc.
|
- USD
|
-Infinity%
|
Cardio Diagnostics Holdings, Inc.
|
17.06 Thousand USD
|
-19653.882%
|
Moolec Science SA
|
905.04 Thousand USD
|
-272.466%
|
Biomea Fusion, Inc.
|
- USD
|
-Infinity%
|
RenovoRx, Inc.
|
- USD
|
-Infinity%
|
Geron Corporation
|
237 Thousand USD
|
-1322.363%
|
Mereo BioPharma Group plc
|
10 Million USD
|
66.29%
|
Verrica Pharmaceuticals Inc.
|
5.12 Million USD
|
34.212%
|
Royalty Pharma plc
|
2.35 Billion USD
|
99.857%
|
Atea Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Greenwich LifeSciences, Inc.
|
- USD
|
-Infinity%
|
Calithera Biosciences, Inc.
|
- USD
|
-Infinity%
|
TFF Pharmaceuticals, Inc.
|
733.87 Thousand USD
|
-359.345%
|
Mersana Therapeutics, Inc.
|
36.85 Million USD
|
90.853%
|
Humacyte, Inc.
|
- USD
|
-Infinity%
|
Structure Therapeutics Inc.
|
- USD
|
-Infinity%
|
NLS Pharmaceutics AG
|
- USD
|
-Infinity%
|
Genelux Corporation
|
170 Thousand USD
|
-1882.941%
|
ESSA Pharma Inc.
|
- USD
|
-Infinity%
|
aTyr Pharma, Inc.
|
353 Thousand USD
|
-854.958%
|
Notable Labs, Ltd.
|
310 Thousand USD
|
-987.419%
|
Alzamend Neuro, Inc.
|
- USD
|
-Infinity%
|
Mustang Bio, Inc.
|
- USD
|
-Infinity%
|
Immunovant, Inc.
|
- USD
|
-Infinity%
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
Vericel Corporation
|
197.51 Million USD
|
98.293%
|
Halozyme Therapeutics, Inc.
|
829.25 Million USD
|
99.593%
|
Akari Therapeutics, Plc
|
- USD
|
-Infinity%
|
Acasti Pharma Inc.
|
- USD
|
-Infinity%
|
MiNK Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Vaxcyte, Inc.
|
- USD
|
-Infinity%
|
Orgenesis Inc.
|
530 Thousand USD
|
-536.038%
|
Spruce Biosciences, Inc.
|
10.08 Million USD
|
66.587%
|
NeuroBo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
GH Research PLC
|
- USD
|
-Infinity%
|
Tempest Therapeutics, Inc.
|
- USD
|
-Infinity%
|
PepGen Inc.
|
- USD
|
-Infinity%
|
Moleculin Biotech, Inc.
|
- USD
|
-Infinity%
|
Relmada Therapeutics, Inc.
|
- USD
|
-Infinity%
|
BriaCell Therapeutics Corp.
|
- USD
|
-Infinity%
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
Silo Pharma, Inc.
|
72.1 Thousand USD
|
-4575.321%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
- USD
|
-Infinity%
|
Belite Bio, Inc
|
- USD
|
-Infinity%
|
Pharming Group N.V.
|
245.31 Million USD
|
98.626%
|
XOMA Corporation
|
4.75 Million USD
|
29.151%
|
Reneo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
Bionomics Limited
|
- USD
|
-Infinity%
|
Xencor, Inc.
|
168.33 Million USD
|
97.997%
|
Replimune Group, Inc.
|
- USD
|
-Infinity%
|
Pyxis Oncology, Inc.
|
- USD
|
-Infinity%
|
Cassava Sciences, Inc.
|
- USD
|
-Infinity%
|
Vanda Pharmaceuticals Inc.
|
192.64 Million USD
|
98.25%
|
Estrella Immunopharma, Inc.
|
- USD
|
-Infinity%
|
Turnstone Biologics Corp.
|
19.3 Million USD
|
82.539%
|
Windtree Therapeutics, Inc.
|
- USD
|
-Infinity%
|
GeoVax Labs, Inc.
|
- USD
|
-Infinity%
|
MEI Pharma, Inc.
|
65.29 Million USD
|
94.837%
|
Olema Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Cardio Diagnostics Holdings, Inc.
|
17.06 Thousand USD
|
-19653.882%
|
Bio-Path Holdings, Inc.
|
- USD
|
-Infinity%
|
Enlivex Therapeutics Ltd.
|
- USD
|
-Infinity%
|
CollPlant Biotechnologies Ltd.
|
10.95 Million USD
|
69.24%
|
scPharmaceuticals Inc.
|
13.59 Million USD
|
75.2%
|
HilleVax, Inc.
|
- USD
|
-Infinity%
|
Vera Therapeutics, Inc.
|
1.86 Million USD
|
-81.042%
|
Tharimmune, Inc.
|
- USD
|
-Infinity%
|
Genprex, Inc.
|
- USD
|
-Infinity%
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
Immunic, Inc.
|
- USD
|
-Infinity%
|
Atossa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Aptorum Group Limited
|
431.37 Thousand USD
|
-681.449%
|
Soleno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
OKYO Pharma Limited
|
- USD
|
-Infinity%
|
Carmell Therapeutics Corporation
|
- USD
|
-Infinity%
|
Achieve Life Sciences, Inc.
|
- USD
|
-Infinity%
|
Ocean Biomedical, Inc.
|
- USD
|
-Infinity%
|
Amicus Therapeutics, Inc.
|
399.35 Million USD
|
99.156%
|
Salarius Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
bluebird bio, Inc.
|
29.49 Million USD
|
88.572%
|
DBV Technologies S.A.
|
15.72 Million USD
|
78.567%
|
Compugen Ltd.
|
33.45 Million USD
|
89.925%
|
Protagenic Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Peak Bio, Inc.
|
367.87 Thousand USD
|
-816.339%
|
Vincerx Pharma, Inc.
|
- USD
|
-Infinity%
|
Fresh Tracks Therapeutics, Inc.
|
8 Million USD
|
57.894%
|
Sensei Biotherapeutics, Inc.
|
- USD
|
-Infinity%
|
Orchestra BioMed Holdings, Inc.
|
2.76 Million USD
|
-22.138%
|
Zevra Therapeutics, Inc.
|
27.46 Million USD
|
87.724%
|
Acrivon Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Benitec Biopharma Inc.
|
216 Thousand USD
|
-1460.648%
|
Spyre Therapeutics, Inc.
|
886 Thousand USD
|
-280.474%
|
Adicet Bio, Inc.
|
- USD
|
-Infinity%
|
Prime Medicine, Inc.
|
- USD
|
-Infinity%
|
Aditxt, Inc.
|
645.17 Thousand USD
|
-422.493%
|
Madrigal Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Estrella Immunopharma, Inc.
|
- USD
|
-Infinity%
|
Quantum-Si incorporated
|
1.08 Million USD
|
-211.553%
|
GlycoMimetics, Inc.
|
10 Thousand USD
|
-33610.0%
|
PolyPid Ltd.
|
- USD
|
-Infinity%
|
Aileron Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Invivyd, Inc.
|
- USD
|
-Infinity%
|
Quoin Pharmaceuticals, Ltd.
|
- USD
|
-Infinity%
|
Rigel Pharmaceuticals, Inc.
|
116.88 Million USD
|
97.116%
|
CorMedix Inc.
|
- USD
|
-Infinity%
|
Instil Bio, Inc.
|
- USD
|
-Infinity%
|
Recursion Pharmaceuticals, Inc.
|
44.57 Million USD
|
92.437%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
50 Million USD
|
93.258%
|
Finch Therapeutics Group, Inc.
|
107 Thousand USD
|
-3050.467%
|
Spero Therapeutics, Inc.
|
96.73 Million USD
|
96.515%
|
Alpha Tau Medical Ltd.
|
- USD
|
-Infinity%
|
AbCellera Biologics Inc.
|
38.02 Million USD
|
91.135%
|
Ocular Therapeutix, Inc.
|
58.44 Million USD
|
94.232%
|
Surrozen, Inc.
|
- USD
|
-Infinity%
|
Janux Therapeutics, Inc.
|
8.08 Million USD
|
58.295%
|
Verona Pharma plc
|
- USD
|
-Infinity%
|
Terns Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Vir Biotechnology, Inc.
|
86.18 Million USD
|
96.088%
|
Evaxion Biotech A/S
|
73.11 Thousand USD
|
-4510.734%
|
Verve Therapeutics, Inc.
|
11.75 Million USD
|
71.33%
|
Shattuck Labs, Inc.
|
1.65 Million USD
|
-103.44%
|
AlloVir, Inc.
|
- USD
|
-Infinity%
|
BioVie Inc.
|
- USD
|
-Infinity%
|
Codexis, Inc.
|
70.14 Million USD
|
95.194%
|
SELLAS Life Sciences Group, Inc.
|
- USD
|
-Infinity%
|
Lexaria Bioscience Corp.
|
226.2 Thousand USD
|
-1390.221%
|
Agenus Inc.
|
156.31 Million USD
|
97.843%
|
Virax Biolabs Group Limited
|
156.41 Thousand USD
|
-2055.109%
|
Lantern Pharma Inc.
|
- USD
|
-Infinity%
|
Viridian Therapeutics, Inc.
|
314 Thousand USD
|
-973.567%
|
eFFECTOR Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Immix Biopharma, Inc.
|
- USD
|
-Infinity%
|
Celcuity Inc.
|
- USD
|
-Infinity%
|
Cardiff Oncology, Inc.
|
488 Thousand USD
|
-590.779%
|
Acumen Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
IN8bio, Inc.
|
- USD
|
-Infinity%
|
Avenue Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Trevi Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Lexicon Pharmaceuticals, Inc.
|
1.2 Million USD
|
-179.983%
|
Liquidia Corporation
|
17.48 Million USD
|
80.724%
|
Quantum-Si incorporated
|
1.08 Million USD
|
-211.553%
|
Pasithea Therapeutics Corp.
|
- USD
|
-Infinity%
|
Xenon Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Sol-Gel Technologies Ltd.
|
1.55 Million USD
|
-116.924%
|
United Therapeutics Corporation
|
2.32 Billion USD
|
99.855%
|
Solid Biosciences Inc.
|
- USD
|
-Infinity%
|
Immuneering Corporation
|
- USD
|
-Infinity%
|
Alpha Tau Medical Ltd.
|
- USD
|
-Infinity%
|
uniQure N.V.
|
15.84 Million USD
|
78.722%
|
Xilio Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Enveric Biosciences, Inc.
|
- USD
|
-Infinity%
|
Poseida Therapeutics, Inc.
|
64.7 Million USD
|
94.79%
|
Longboard Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
PMV Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Elevai Labs, Inc. Common Stock
|
1.71 Million USD
|
-96.836%
|
Cue Biopharma, Inc.
|
5.49 Million USD
|
38.597%
|
Nuvectis Pharma, Inc.
|
- USD
|
-Infinity%
|
ARS Pharmaceuticals, Inc.
|
30 Thousand USD
|
-11136.667%
|
Zura Bio Limited
|
- USD
|
-Infinity%
|
Forte Biosciences, Inc.
|
- USD
|
-Infinity%
|
Elevation Oncology, Inc.
|
- USD
|
-Infinity%
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Immunome, Inc.
|
14.01 Million USD
|
75.952%
|
Compass Therapeutics, Inc.
|
- USD
|
-Infinity%
|
enGene Holdings Inc. Warrants
|
- USD
|
-Infinity%
|
Inovio Pharmaceuticals, Inc.
|
832.01 Thousand USD
|
-305.163%
|
LENZ Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Altimmune, Inc.
|
426 Thousand USD
|
-691.315%
|
Milestone Pharmaceuticals Inc.
|
1 Million USD
|
-237.1%
|
Rallybio Corporation
|
- USD
|
-Infinity%
|
Plus Therapeutics, Inc.
|
4.91 Million USD
|
31.386%
|
Dianthus Therapeutics, Inc.
|
2.82 Million USD
|
-19.285%
|
Moolec Science SA
|
905.04 Thousand USD
|
-272.466%
|
Anebulo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
XTL Biopharmaceuticals Ltd.
|
- USD
|
-Infinity%
|
Tourmaline Bio, Inc.
|
- USD
|
-Infinity%
|
NeurAxis, Inc.
|
2.46 Million USD
|
-37.03%
|
Maravai LifeSciences Holdings, Inc.
|
288.94 Million USD
|
98.833%
|
Lumos Pharma, Inc.
|
2.05 Million USD
|
-64.359%
|
enGene Holdings Inc. Common Stock
|
- USD
|
-Infinity%
|
180 Life Sciences Corp.
|
- USD
|
-Infinity%
|
NKGen Biotech, Inc. Warrants
|
- USD
|
-Infinity%
|
Opiant Pharmaceuticals, Inc.
|
40.72 Million USD
|
91.723%
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
Nutriband Inc.
|
2.08 Million USD
|
-61.654%
|
CG Oncology, Inc. Common stock
|
204 Thousand USD
|
-1552.451%
|
argenx SE
|
1.22 Billion USD
|
99.725%
|
Neurogene Inc.
|
- USD
|
-Infinity%
|
Mirum Pharmaceuticals, Inc.
|
186.37 Million USD
|
98.191%
|
Kintara Therapeutics, Inc.
|
- USD
|
-Infinity%
|
CervoMed Inc.
|
7.14 Million USD
|
52.819%
|
CARGO Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Sesen Bio, Inc.
|
40 Million USD
|
91.573%
|
AnaptysBio, Inc.
|
17.15 Million USD
|
80.352%
|
Design Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Leap Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Seelos Therapeutics, Inc.
|
2.2 Million USD
|
-53.019%
|
Achilles Therapeutics plc
|
- USD
|
-Infinity%
|
NeuroSense Therapeutics Ltd.
|
- USD
|
-Infinity%
|
ORIC Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Fractyl Health, Inc. Common Stock
|
120 Thousand USD
|
-2709.167%
|
Rani Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
MoonLake Immunotherapeutics
|
- USD
|
-Infinity%
|
Palisade Bio, Inc.
|
250 Thousand USD
|
-1248.4%
|
Beam Therapeutics Inc.
|
377.7 Million USD
|
99.108%
|
AEON Biopharma, Inc.
|
- USD
|
-Infinity%
|
Enliven Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Kiora Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Iovance Biotherapeutics, Inc.
|
1.18 Million USD
|
-183.516%
|
Taysha Gene Therapies, Inc.
|
15.45 Million USD
|
78.183%
|
Athira Pharma, Inc.
|
- USD
|
-Infinity%
|
Vaccinex, Inc.
|
570 Thousand USD
|
-491.404%
|
HCW Biologics Inc.
|
2.84 Million USD
|
-18.622%
|
XOMA Corporation
|
4.75 Million USD
|
29.151%
|
Nektar Therapeutics
|
90.12 Million USD
|
96.26%
|
Arvinas, Inc.
|
78.5 Million USD
|
95.706%
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
Merus N.V.
|
43.94 Million USD
|
92.329%
|
Omega Therapeutics, Inc.
|
3.09 Million USD
|
-8.953%
|
Quince Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Rezolute, Inc.
|
- USD
|
-Infinity%
|
Clene Inc.
|
654 Thousand USD
|
-415.443%
|
Indaptus Therapeutics, Inc.
|
- USD
|
-Infinity%
|
BeyondSpring Inc.
|
1.75 Million USD
|
-92.519%
|
Allarity Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Phio Pharmaceuticals Corp.
|
- USD
|
-Infinity%
|
Peak Bio, Inc.
|
367.87 Thousand USD
|
-816.339%
|
Werewolf Therapeutics, Inc.
|
19.94 Million USD
|
83.097%
|
Krystal Biotech, Inc.
|
50.69 Million USD
|
93.351%
|
Karyopharm Therapeutics Inc.
|
146.03 Million USD
|
97.692%
|
SpringWorks Therapeutics, Inc.
|
5.44 Million USD
|
38.113%
|
Lipella Pharmaceuticals Inc.
|
449.61 Thousand USD
|
-649.749%
|
MannKind Corporation
|
198.96 Million USD
|
98.306%
|
Ikena Oncology, Inc.
|
9.16 Million USD
|
63.199%
|
Cyclerion Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Gyre Therapeutics, Inc.
|
113.45 Million USD
|
97.029%
|
Gossamer Bio, Inc.
|
- USD
|
-Infinity%
|
CohBar, Inc.
|
- USD
|
-Infinity%
|
Cognition Therapeutics, Inc.
|
- USD
|
-Infinity%
|
NRx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Legend Biotech Corporation
|
285.14 Million USD
|
98.818%
|
Mural Oncology plc
|
- USD
|
-Infinity%
|
Biora Therapeutics, Inc.
|
4000.00 USD
|
-84175.0%
|
PaxMedica, Inc. Common Stock
|
- USD
|
-Infinity%
|
Disc Medicine, Inc.
|
- USD
|
-Infinity%
|
Champions Oncology, Inc.
|
50.15 Million USD
|
93.279%
|
REGENXBIO Inc.
|
90.24 Million USD
|
96.264%
|
Ensysce Biosciences, Inc.
|
2.23 Million USD
|
-51.131%
|
Anavex Life Sciences Corp.
|
- USD
|
-Infinity%
|
Cellectar Biosciences, Inc.
|
- USD
|
-Infinity%
|
Edgewise Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Vaxart, Inc.
|
7.37 Million USD
|
54.316%
|
PharmaCyte Biotech, Inc.
|
- USD
|
-Infinity%
|
Aldeyra Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Cellectis S.A.
|
755 Thousand USD
|
-346.49%
|
Longeveron Inc.
|
709 Thousand USD
|
-375.458%
|
Repare Therapeutics Inc.
|
51.13 Million USD
|
93.407%
|
Sarepta Therapeutics, Inc.
|
1.24 Billion USD
|
99.729%
|
Inozyme Pharma, Inc.
|
- USD
|
-Infinity%
|
Revolution Medicines, Inc.
|
11.58 Million USD
|
70.889%
|
Nymox Pharmaceutical Corporation
|
- USD
|
-Infinity%
|
Third Harmonic Bio, Inc.
|
- USD
|
-Infinity%
|
ArriVent BioPharma, Inc. Common Stock
|
- USD
|
-Infinity%
|
AN2 Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Anixa Biosciences, Inc.
|
210 Thousand USD
|
-1505.238%
|
Vertex Pharmaceuticals Incorporated
|
9.86 Billion USD
|
99.966%
|
Denali Therapeutics Inc.
|
330.53 Million USD
|
98.98%
|
Revelation Biosciences, Inc.
|
- USD
|
-Infinity%
|
Veru Inc.
|
16.29 Million USD
|
79.315%
|
Corvus Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Cingulate Inc.
|
- USD
|
-Infinity%
|
Passage Bio, Inc.
|
- USD
|
-Infinity%
|
Context Therapeutics Inc.
|
- USD
|
-Infinity%
|
Exicure, Inc.
|
- USD
|
-Infinity%
|
Day One Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Oramed Pharmaceuticals Inc.
|
2.7 Million USD
|
-24.713%
|
Revolution Medicines, Inc. Warrant
|
11.58 Million USD
|
70.889%
|
Scinai Immunotherapeutics Ltd.
|
- USD
|
-Infinity%
|
Rhythm Pharmaceuticals, Inc.
|
77.42 Million USD
|
95.646%
|
Nuvalent, Inc.
|
- USD
|
-Infinity%
|
ABVC BioPharma, Inc.
|
152.43 Thousand USD
|
-2111.507%
|
Carisma Therapeutics, Inc.
|
14.91 Million USD
|
77.405%
|
Unicycive Therapeutics, Inc.
|
675 Thousand USD
|
-399.407%
|
OmniAb, Inc.
|
34.16 Million USD
|
90.133%
|
Anew Medical, Inc.
|
- USD
|
-Infinity%
|
Fennec Pharmaceuticals Inc.
|
21.25 Million USD
|
84.138%
|
Lipocine Inc.
|
-2.85 Million USD
|
218.247%
|
Lexeo Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Nautilus Biotechnology, Inc.
|
- USD
|
-Infinity%
|
SAB Biotherapeutics, Inc.
|
2.23 Million USD
|
-50.559%
|
G1 Therapeutics, Inc.
|
82.51 Million USD
|
95.914%
|
Bellerophon Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Sage Therapeutics, Inc.
|
86.45 Million USD
|
96.101%
|
Ocugen, Inc.
|
6.03 Million USD
|
44.152%
|
Mind Medicine (MindMed) Inc.
|
- USD
|
-Infinity%
|
Q32 Bio Inc.
|
1.15 Million USD
|
-191.609%
|
Brainstorm Cell Therapeutics Inc.
|
- USD
|
-Infinity%
|
Alumis Inc. Common Stock
|
- USD
|
-Infinity%
|
Equillium, Inc.
|
36.08 Million USD
|
90.658%
|
Kyverna Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Coya Therapeutics, Inc.
|
6 Million USD
|
43.837%
|
CNS Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Galera Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Evelo Biosciences, Inc.
|
- USD
|
-Infinity%
|
Comera Life Sciences Holdings, Inc.
|
633.1 Thousand USD
|
-432.458%
|
Dominari Holdings Inc.
|
2.03 Million USD
|
-65.326%
|
Edesa Biotech, Inc.
|
- USD
|
-Infinity%
|
vTv Therapeutics Inc.
|
- USD
|
-Infinity%
|
Bio-Techne Corporation
|
1.15 Billion USD
|
99.709%
|
Agios Pharmaceuticals, Inc.
|
26.82 Million USD
|
87.432%
|
Harmony Biosciences Holdings, Inc.
|
582.02 Million USD
|
99.421%
|
Prelude Therapeutics Incorporated
|
- USD
|
-Infinity%
|
Candel Therapeutics, Inc.
|
- USD
|
-Infinity%
|
iTeos Therapeutics, Inc.
|
12.59 Million USD
|
73.235%
|
Nkarta, Inc.
|
- USD
|
-Infinity%
|
BioCardia, Inc.
|
477 Thousand USD
|
-606.709%
|
Iterum Therapeutics plc
|
- USD
|
-Infinity%
|